Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Timothy R. Wright
Age : 63
Public asset : 7,295,353 USD
Linked companies : Agenus Inc. - MiMedx Group, Inc.
Timothy R. Wright is a businessperson who founded Mortimer Capital and who has been at the helm of 7 different companies.

He is Chief Executive Officer & Director at MiMedx Group, Inc.

He is also on the board of Agenus, Inc. and Ohio State Innovation Foundation and Partner at Signal Hill Advisors LLC.

In his past career Timothy R. Wright was Chairman & Chief Executive Officer of Curaxis Pharmaceutical Corp., President & Interim Chief Executive Officer at AAIPharma, Inc., President & Chief Executive Officer for M2Gen Corp., Chief Operating Officer for Xanodyne Pharmaceuticals, Inc., Senior Vice President-Healthcare Product Services at Cardinal Health, Inc., Executive VP-Strategy & Business Development at Teva Pharmaceutical Industries Ltd., Chairman for ParagonRx International LLC, Director at Ohio State University Comprehensive Cancer Center, President at Elan Biopharmaceuticals, Inc., SVP-Strategy & Corporate Business Development at DuPont Merck Pharmaceutical Co., President-Pharmaceuticals & Senior Vice President at Covidien New Zealand Ltd. and President-Pharmaceuticals & Senior Vice President at Covidien Ltd.

He received an undergraduate degree from The Ohio State University.

Current positions of Timothy R. Wright 
NameTitle Since
Agenus Inc.
(Biotechnology & Medical Research)
Lead Independent Director 2009
MiMedx Group, Inc.
(Biotechnology & Medical Research)
Chief Executive Officer & Director 2019
Ohio State Innovation Foundation Director -
Signal Hill Advisors LLC Partner 2011

Holdings of Timothy R. Wright 
MiMedx Group, Inc. (MDXG)
(Biotechnology & Medical Research)
1,823,3241.62%7,202,130 USD
Agenus Inc. (AGEN)
(Biotechnology & Medical Research)
50,3910.020%93,223 USD

Timothy R. Wright: Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
05/09ELON MUSK : Musk tweet on Japan doomed by low birthrate provokes anger - but not just at him
More news

© 2022 People and Ownership :   
Timothy R. Wright : Connections